<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Turk J Obstet Gynecol</journal-id><journal-id journal-id-type="iso-abbrev">Turk J Obstet Gynecol</journal-id><journal-id journal-id-type="publisher-id">TJOD</journal-id><journal-title-group><journal-title>Turkish Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="ppub">2149-9322</issn><issn pub-type="epub">2149-9330</issn><publisher><publisher-name>Galenos Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29662710</article-id><article-id pub-id-type="pmc">5894530</article-id><article-id pub-id-type="doi">10.4274/tjod.47855</article-id><article-id pub-id-type="publisher-id">16866</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Investigation</subject></subj-group></article-categories><title-group><article-title>Natural cycle versus artificial cycle in frozen-thawed embryo transfer: A randomized prospective trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Agha-Hosseini</surname><given-names>Marzieh</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hashemi</surname><given-names>Leila</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Aleyasin</surname><given-names>Ashraf</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghasemi</surname><given-names>Marzieh</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sarvi</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref rid="COR1" ref-type="corresp">*</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3467-7605</contrib-id></contrib><contrib contrib-type="author"><name><surname>Shabani Nashtaei</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Khodarahmian</surname><given-names>Mahshad</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Tehran University of Medical Sciences Faculty of Medicine, Shariati Hospital, Department of Infertility, Tehran, Iran</aff><aff id="A2">
<label>2</label>Zahedan University of Medical Sciences, Aliebneabitaleb Hospital, Pregnancy Health Research Center, Department of Obstetrics and Gynecology, Zahedan, Iran</aff><aff id="A3">
<label>3</label>Tehran University of Medical Sciences Faculty of Medicine, Department of Anatomy, Tehran, Iran</aff><author-notes><corresp id="COR1">* Address for Correspondence: Tehran University of Medical Sciences Faculty of Medicine, Shariati Hospital, Department of Infertility, Tehran, Iran Phone: +98 912 5463230 E-mail:<email>sarvi.fateme@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>29</day><month>3</month><year>2018</year></pub-date><volume>15</volume><issue>1</issue><fpage>12</fpage><lpage>17</lpage><history><date date-type="received"><day>11</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>3</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9;Copyright 2018 by Turkish Society of Obstetrics and Gynecology&#x0000d;
Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House.</copyright-statement><copyright-year>2018</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/2.5/" license-type="open-access"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objective:</title><p>To investigate whether there was a difference in pregnancy outcomes between modified natural cycle frozen-thawed embryo transfer (NC-FET) cycles and artificial cycles (AC)-FET in women who all had regular menstrual cycles.</p></sec><sec><title>Materials and Methods:</title><p>One hundred seventy patients who met the inclusion criteria and had at least two cryopreserved embryos were included in a prospective randomized controlled trial. Eighty-five patients were randomized based on Bernoulli distribution into the following two groups: 1) Modified NC-FET using human chorionic gonadotropin for ovulation induction and 2) AC-FET, in which endometrial timing was programmed with estrogen and progesterone. The main studied outcome measure was the clinical pregnancy rate per cycle.</p></sec><sec><title>Results:</title><p>No significant differences were found between the two groups with regard to the chemical, clinical, and ongoing pregnancy rates (48.2% vs 45.9%, p&#x0003e;0.05; 38.9% vs 35.3%, p&#x0003e;0.05; and 37.6% vs 34.1%, p&#x0003e;0.05, respectively), as well as the live birth or miscarriage rates per cycle (35.3% vs 31.8%, p&#x0003e;0.05; and 1.2% vs 1.2%, p&#x0003e;0.05, respectively).</p></sec><sec><title>Conclusion:</title><p>These findings suggest that although both FET protocols are equally effective in terms of pregnancy outcomes in women with regular menstrual cycles, NC-FET is more favorable because it requires no medication, has no adverse events, and has a significant cost reduction.</p></sec></abstract><kwd-group><kwd>Frozen-thawed embryo transfer</kwd><kwd>artificial cycle</kwd><kwd>natural cycle</kwd><kwd>clinical pregnancy rate</kwd></kwd-group></article-meta></front><body><p>
<bold>PRECIS:</bold> Modified natural cycles are recommended in frozen&#x02013;thawed embryo transfer cycles, at least in patients with regular menstrual cycles due to numerous advantages including no medication, no adverse events, and a significant cost reduction.</p><sec sec-type="intro" id="s2"><title>Introduction</title><p>Many patients have benefited greatly from frozen&#x02013;thawed embryo transfer (FET) cycles to achieve pregnancy following either successful <italic>in vitro</italic> fertilization (IVF) or failed fresh embryo transfer (ET) cycles<sup>(<xref rid="ref1" ref-type="bibr">1</xref>)</sup>. The cost-effective FET cycles improve the cumulative pregnancy rate per oocyte retrieval<sup>(<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref>)</sup>. Additionally, IVF-associated complications such as Hyperstimulation syndrome and multiple births can effectively be prevented by FET<sup>(<xref rid="ref5" ref-type="bibr">5</xref>)</sup>.</p><p>An important factor in improving FET is optimal endometrial receptivity as well as synchronization between embryonic and endometrial developments<sup>(<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref8" ref-type="bibr">8</xref>)</sup>. To achieve this, several methods for endometrium preparation have been proposed. In FET cycles, the transfer of embryos may be timed either in natural cycles after spontaneous ovulation or in artificial hormonally-controlled cycles using sequentially administered exogenous estrogen (E) and progesterone<sup>(<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref12" ref-type="bibr">12</xref>)</sup>. Natural cycle-FET (NC-FET) may be preferable for women with regular menstrual cycles because it requires less medication and has a lower cost for patients. Nevertheless, even in these women, ovulation may not always happen or an unexpected ovulation may occur. Thus, the timing of FET can also be problematic. Furthermore, the predictability and reliability of artificial cycle-FET (AC-FET) cycles have been favored in clinics<sup>(<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref6" ref-type="bibr">6</xref>)</sup>. A recent systematic review and meta-analysis of the literature that compared different protocols for FET reported no differences in the clinical pregnancy rate, ongoing pregnancy rate, and live birth rate<sup>(<xref rid="ref11" ref-type="bibr">11</xref>)</sup>. However, some controversy exists because some investigators reported better pregnancy outcomes with AC-FET,<sup>(<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref13" ref-type="bibr">13</xref>)</sup> whereas the results of some retrospective studies demonstrated the superiority of NC-FET<sup>(<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>)</sup>. Because there are insufficient well-designed randomized controlled trials (RCTs) to determine which type of cycle regimen is superior in FET cycles<sup>(<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref12" ref-type="bibr">12</xref>)</sup> and considering the existence of conflicting reports in this regard, this study focused on comparing two different protocols for endometrial preparation: modified NC-FET versus AC-FET in women who all had regular menstrual cycles. The chemical, clinical, and ongoing pregnancy rates, miscarriage and live birth rates were compared in these two distinct FET cycles to identify predictive factors and to influence the reproductive outcome.</p></sec><sec sec-type="materials|methods" id="s3"><title>Materials and Methods</title><p>After obtaining institutional review board approval, this prospective randomized clinical trial was approved by the Ethics Committee of Tehran University of Medical Sciences (approval number: IR.TUMS.REC.1394.2051) and written informed consent was obtained from all participants. All women who were aged between 18 and 40 years and had regular menses (25-34 days) and who had at least two cryopreserved embryos derived from intracytoplasmic sperm injection (ICSI) treatment cycles from January 2012 to December 2014 were referred to the infertility clinic of Shariati Hospital (a university teaching hospital) and were enrolled in the study. The period of study was from January 2015 to July 2016. Women with endometriosis, immune diseases, recurrent abortion, donated sperm or oocyte, uterine abnormality, ovarian cyst or previous ovarian surgery, history of previous IVF failure, and any known contraindications or allergy for oral estradiol or progesterone therapy were excluded from participating in the study. In addition, patients were excluded if their clinical history included percutaneous epididymal sperm aspiration or testicular sperm extraction. The enrolled women were divided randomly into two groups to undergo either a modified natural cycle FET (group A) or artificial cycle FET (group B) using computerized software in a 1:1 fashion (<xref ref-type="fig" rid="f1">Figure 1</xref>). The sequence of allocation to the two groups was generated by the aforementioned software and then the treating physicians (n=2) gave treatment based on the allocated chart. A baseline transvaginal ultrasound (Siemens, Sonoline G20) using a 7.5 MH transvaginal probe was performed in all patients by the same attending physician on the 2<sup>nd</sup> or 3<sup>rd</sup> days of the menstrual cycle to assess the endometrium and rule out the presence of an ovarian cyst.</p><sec id="s3a"><title>The endometrial preparation protocols</title><p>Based on the study protocol and inclusion criteria, 85 patients were considered as group A (modified NC-FET) and 85 were classified as group B (AC-FET) and were assigned to receive the related protocol. The demographic characteristics and clinical data of the two groups are given in <xref ref-type="table" rid="t1">Table 1</xref>. </p></sec><sec id="s3b"><title>Modified natural cycle frozen&#x02013;thawed embryo transfer</title><p>An ultrasound examination was performed on days 10 to 12 of the cycle after a spontaneous menses to detect the leading follicle. When at least one dominant follicle reached &#x02265;18 mm in diameter and the thickness of the endometrium was at least 8 mm, a bolus of 10.000 IU of human chorionic gonadotropin (hCG) (Pregnyl; N.V. Organon, Oss, The Netherlands) was injected intramuscularly for the induction of ovulation and the embryos were thawed and transferred 4 days later.</p></sec><sec id="s3c"><title>Artificial cycle frozen&#x02013;thawed embryo transfer</title><p>From the 21<sup>st</sup> day of the previous cycle, 500 &#x000b5;g/day of buserelin acetate (Suprecur; Hoechst UK Ltd, Hounslow, UK) was subcutaneously injected. Oral estradiol valerate (Progynova, Bayer, Germany) was then administered from day 2 of the next cycle from 2 mg/d to 2 mg/d &#x00427;4. The E dosage was adjusted based on the endometrial thickness as assessed using transvaginal ultrasound. After a baseline transvaginal ultrasound, a second ultrasound examination was performed on days 10 to 12 for the endometrial thickness assessment. Four hundred milligrams &#x00427;2 daily progesterone vaginal suppositories (Cyclogest, Actavis, Devon, UK) were administered in the following 3 days when the endometrium reached a thickness of 8 mm or maximum. ET was performed after 3 days of progesterone administration. Luteal phase support commenced on the day of ET in all the participants, using 400 mg &#x00427;2 daily progesterone vaginal suppositories (Cyclogest, Actavis, Devon, UK). Serum beta-hCG levels were evaluated for all patients 14 to 16 days after ET to confirm biochemical pregnancy. Progestin support continued up to the end of the 12<sup>th</sup> weeks&#x02019; gestation if pregnancy was achieved. Vitrification and thawing of the cleavage-stage embryo were implemented using the same method reported in a previous publication<sup>(<xref rid="ref16" ref-type="bibr">16</xref>)</sup>. The embryos were thawed on the day of the ET and those that were classified as grade I or grade II (according to cleavage stage, blastomere size and shape, and fragmentation) and had at least 50% intact blastomeres were transferred. The number of transferred embryos per cycle was limited to a maximum of three and was dependent upon the number of previous treatments, the number of embryos frozen in the same straw, and the quality of available embryos. Moreover, similar techniques were used by the two expert physicians who performed ET. </p></sec><sec id="s3d"><title>Outcome measures</title><p>The primary outcome measure was clinical pregnancy. The secondary outcomes were biochemical pregnancy, ongoing pregnancy, live birth rate, and miscarriage rate. We applied the term &#x0201c;biochemical pregnancy&#x0201d; to an elevated serum beta-hCG level two weeks after hCG administration. Clinical pregnancy was established by the detection of a fetal heartbeat through transvaginal ultrasound in the 6<sup>th</sup> week. &#x0201c;ongoing pregnancy&#x0201d; referred to any pregnancy beyond 20 weeks of gestation. The miscarriage rate was measured using transvaginal ultrasonography and a decrease in serum beta-hCG level. All pregnant women were followed up to obtain delivery data. A live birth was defined as the completion of expulsion or extraction of a live baby from its mother. </p></sec><sec id="s3e"><title>Statistical Analysis</title><p>To have power of 0.8 to detect a 10% difference in clinical pregnancy rates between the study groups with a significance level of 0.05, we required 80 patients in each study group. Data are expressed as mean &#x000b1; standard deviation for descriptive statistics when normally distributed, otherwise as median and range. All the analyses were performed using the SPSS software (version 17.0 for Windows; SPSS Inc., Chicago, IL, USA). The normality of distribution was checked using the Kolmogorov-Smirnov test. The comparison of the treatment outcomes between the two protocols was performed using the independent Sample t-test and/or chi-square test (or Fisher&#x02019;s exact test if required). The level of significance was p&#x0003c;0.05. </p></sec></sec><sec sec-type="results" id="s4"><title>Results</title><p>A total of 205 women undergoing ICSI who had cryopreserved embryos were evaluated, 170 of whom were randomized to receive either modified NC-FET cycles or AC-FET (<xref ref-type="fig" rid="f1">Figure 1</xref>). There were no statistically significant differences between the two groups terms of age, duration, type, and causes of infertility, day 3 follicle stimulating hormone or body mass index (<xref ref-type="table" rid="t1">Table 1</xref>). The characteristics and pregnancy outcomes for both cycle types are shown in <xref ref-type="table" rid="t2">Table 2</xref>. No significant difference was found between the NC-FET and the AC-FET groups regarding the average number of dominant follicles, endometrial thickness, the average number of transferred embryos, and embryo grade. Of the 170 cycles, a total of 63 clinical pregnancies occurred in the NC-FET and the AC-FET groups [33 (38.9%) versus 30 (35.3%) clinical pregnancies; p=0.4, respectively]. As demonstrated in <xref ref-type="table" rid="t2">Table 2</xref>, there were no significant differences between the two cycle types in terms of chemical, clinical, and ongoing pregnancy rates, miscarriage and live birth rates.</p></sec><sec sec-type="discussion" id="s5"><title>Discussion</title><p>This prospective RCT demonstrated that there were no differences in FET outcomes between modified natural and artificial cycles in patients with regular menstrual cycles. In the present study, patients in the modified natural cycle group received supplemental hCG (as a trigger to ovulation) and transvaginal progesterone to offset any probability of poor endogenous luteal phase. Patients with artificial cycles depended entirely on exogenous estradiol and progesterone, with prior gonadotrophin-releasing hormone agonist (GnRHa) down-regulation. The investigation of factors that affect the success of FET has steadily intensified during the past few years in order to transfer fewer embryos and to improve laboratory techniques<sup>(<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref17" ref-type="bibr">17</xref>,<xref rid="ref18" ref-type="bibr">18</xref>,<xref rid="ref19" ref-type="bibr">19</xref>)</sup>. The success of FET is dependent upon the reciprocal interaction between embryo development and the receptive uterus,<sup>(<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref7" ref-type="bibr">7</xref>)</sup> which can be evaluated through endometrial volume, endometrial thickness, and artery blood flow<sup>(<xref rid="ref8" ref-type="bibr">8</xref>)</sup>. Numerous biomarkers, including leukemia inhibitory factor, integrin, and homebox A10<sup>(<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref21" ref-type="bibr">21</xref>,<xref rid="ref22" ref-type="bibr">22</xref>)</sup> have been proposed as reliable markers of a receptive endometrium. Moreover, in older women, endometrial development in the follicular phase can be negatively affected by age, resulting in a lower pregnancy rate<sup>(<xref rid="ref12" ref-type="bibr">12</xref>)</sup>. Adequate endometrial development in FET cycles can be achieved through three frequently used cycle regimens: natural cycles with or without ovulation induction using hCG; hormonally-manipulated artificial cycles using E followed by progesterone to prime the endometrium with/without a GnRHa; and stimulated cycles in which follicular development is supported by follicle-stimulating hormones<sup>(<xref rid="ref15" ref-type="bibr">15</xref>)</sup>. However, no consensus has yet been reached regarding the best FET protocol for endometrial preparation<sup>(<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref15" ref-type="bibr">15</xref>)</sup>. Zheng et al.<sup>(<xref rid="ref5" ref-type="bibr">5</xref>) </sup>reported that ovulation in hormone replacement treatment (HRT) cycles had a detrimental effect on pregnancy, although HRT increased the possibility of pregnancy. This finding is in line with the results of other large retrospective studies<sup>(<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref13" ref-type="bibr">13</xref>)</sup> that also reported a higher positive pregnancy test rate in the substituted cycle with E and progesterone than in natural cycles with hCG or progesterone. In contrast, some studies reported superior pregnancy outcomes in natural cycles<sup>(<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>)</sup>. Higher estradiol (E<sub>2</sub>) levels may interfere with the window of implantation and cause endometrial receptivity and implantation windows to close earlier<sup>(<xref rid="ref23" ref-type="bibr">23</xref>)</sup>. Fritz et al.<sup>(<xref rid="ref24" ref-type="bibr">24</xref>)</sup> also suggested that elevated E<sub>2</sub> levels were associated with lower ongoing pregnancy/live birth rates, possibly due to the opposing effect on the endometrium from excess unopposed E<sub>2</sub> exposure. Furthermore, it has recently been reported that natural cycles have a better effect on endometrial transcriptome than artificial cycles in which E has a stronger negative effect than progesterone on the endometrial transcriptome<sup>(<xref rid="ref25" ref-type="bibr">25</xref>)</sup>. On the other hand, consistent with our findings, comparable FET outcomes have been suggested by several studies in natural and artificial FET cycles<sup>(<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref27" ref-type="bibr">27</xref>,<xref rid="ref28" ref-type="bibr">28</xref>,<xref rid="ref29" ref-type="bibr">29</xref>)</sup>. In addition, a 2017 update of the 2008 Cochrane review also showed no evidence of a difference between the two cycles in rates of live birth or miscarriage rates<sup>(<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref30" ref-type="bibr">30</xref>)</sup>. AC-FET can be more easily scheduled, which leads to a better control of embryo thawing and transfer timing and also decreases cancellation rates compared with NC-FET. This is the result of ovulation suppression and the programmed replacement of exogenous hormones<sup>(<xref rid="ref5" ref-type="bibr">5</xref>)</sup>. However, these advantages are somewhat counterbalanced by its possible adverse effects through exposure to exogenous hormones, higher risk of thrombo-embolic events, and providing a higher financial burden on patients, a burden that many are incapable of overcoming<sup>(<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref31" ref-type="bibr">31</xref>,<xref rid="ref32" ref-type="bibr">32</xref>)</sup>. Although NC-FET is complicated to plan due to its requirement for more frequent ultrasonographic evaluations of the dominant follicle, the risk of unexpected ovulation and insufficient development of the endometrium, its advantages such as being more patient friendly, convenience, less medication, and lower price cannot be denied<sup>(<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref28" ref-type="bibr">28</xref>)</sup>. Consequently, patients should be given the option of NC-FET in order to maintain autonomy in choosing the cycle protocol.</p><sec id="s5a"><title>Study Limitations</title><p>Further clinical trials with larger sample sizes are required to illuminate the clinical and biochemical benefits of NC-FET. </p></sec></sec><sec sec-type="conclusions" id="s6"><title>Conclusion</title><p>In conclusion, based on the results of our study, modified natural cycles should be recommended in FET because they carry numerous advantages and have comparable FET outcomes, it at least in patients with regular menstrual cycles. </p></sec></body><back><ack><p>The authors are grateful to all participants, without whom this work would have been impossible.</p></ack><fn-group><fn id="FN1" fn-type="other"><p><bold>Ethics</bold></p><p><bold>Ethics Committee Approval:</bold> The study was approved by the Ethics Committee of Tehran University of Medical Sciences (approval number: IR.TUMS.REC.1394.2051).</p><p><bold>Informed Consent:</bold> Consent forms were filled out by all participants.</p><p><bold>Peer-review:</bold> External and internal peer-reviewed.</p></fn><fn id="FN2" fn-type="con"><p><bold>Authorship Contributions</bold></p><p>Surgical and Medical Practices: L.H., Concept: M.A.H., F.S., A.A., Design: M.A.H., F.S., A.A., M.G.H., Data Collection or Processing: M.S., M.K., Analysis or Interpretation: M.G., M.S.N., M.K., Literature Search: L.H., F.S., Writing: F.S., M.A.H.</p></fn><fn id="FN3" fn-type="COI-statement"><p><bold>Conflict of interest:</bold> The authors declare that there are no conflicts of interest that could be perceived as prejudicing the impartially of the research reported.</p></fn><fn id="FN4" fn-type="financial-disclosure"><p><bold>Financial Disclosure:</bold> This work was financially supported by the Research Deputy of Tehran University of Medical Sciences (Grant Number: 94-01-01-2051).</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Givens</surname><given-names>CR</given-names></name><name><surname>Markun</surname><given-names>LC</given-names></name><name><surname>Ryan</surname><given-names>IP</given-names></name><name><surname>Chenette</surname><given-names>PE</given-names></name><name><surname>Herbert</surname><given-names>CM</given-names></name><name><surname>Schriock</surname><given-names>ED</given-names></name></person-group><article-title>Outcomes of natural cycles versus programmed cycles for 1677 frozen&#x02013;thawed embryo transfers</article-title><source>Reprod Biomed Online</source><year>2009</year><volume>19</volume><fpage>380</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19778483</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Ai</surname><given-names>J</given-names></name></person-group><article-title>The artificial cycle method improves the pregnancy outcome in frozen&#x02013;thawed embryo transfer: a retrospective cohort study</article-title><source>Gynecol Endocrinol</source><year>2015</year><volume>31</volume><fpage>70</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">25223893</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>McLernon</surname><given-names>D</given-names></name><name><surname>Harrild</surname><given-names>K</given-names></name><name><surname>Bergh</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name><name><surname>de Neubourg</surname><given-names>D</given-names></name><name><surname>Dumoulin</surname><given-names>JC</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials</article-title><source>BMJ</source><year>2010</year><volume>341</volume><fpage>c6945</fpage><pub-id pub-id-type="pmid">21177530</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Veleva</surname><given-names>Z</given-names></name><name><surname>Karinen</surname><given-names>P</given-names></name><name><surname>Tomas</surname><given-names>C</given-names></name><name><surname>Tapanainen</surname><given-names>JS</given-names></name><name><surname>Martikainen</surname><given-names>H</given-names></name></person-group><article-title>Elective single embryo transfer with cryopreservation improves the outcome and diminishes the costs of IVF/ICSI</article-title><source>Hum Reprod</source><year>2009</year><volume>24</volume><fpage>1632</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19318704</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Xiong</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Hormonal replacement treatment improves clinical pregnancy in frozen-thawed embryos transfer cycles: a retrospective cohort study</article-title><source>Am J Transl Res</source><year>2014</year><volume>6</volume><fpage>85</fpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Groenewoud</surname><given-names>ER</given-names></name><name><surname>Macklon</surname><given-names>NS</given-names></name><name><surname>Cohlen</surname><given-names>BJ</given-names></name></person-group><article-title>Cryo-thawed embryo transfer: natural versus artificial cycle</article-title><source>A non-inferiority trial.(ANTARCTICA trial). BMC Womens Health</source><year>2012</year><volume>12</volume><fpage>27</fpage><pub-id pub-id-type="pmid">22950651</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Nardo</surname><given-names>LG</given-names></name><name><surname>Nikas</surname><given-names>G</given-names></name><name><surname>Makrigiannakis</surname><given-names>A</given-names></name></person-group><article-title>Molecules in blastocyst implantation. Role of matrix metalloproteinases, cytokines and growth factors</article-title><source>J Reprod Med</source><year>2003</year><volume>48</volume><fpage>137</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">12698769</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Schild</surname><given-names>RL</given-names></name><name><surname>Knobloch</surname><given-names>C</given-names></name><name><surname>Dorn</surname><given-names>C</given-names></name><name><surname>Fimmers</surname><given-names>R</given-names></name><name><surname>Van Der Ven</surname><given-names>H</given-names></name><name><surname>Hansmann</surname><given-names>M</given-names></name></person-group><article-title>Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow</article-title><source>Fertil Steril</source><year>2001</year><volume>75</volume><fpage>361</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11172840</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Al-Shawaf</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Al-Magid</surname><given-names>Y</given-names></name><name><surname>Seaton</surname><given-names>A</given-names></name><name><surname>Iketubosin</surname><given-names>F</given-names></name><name><surname>Craft</surname><given-names>I</given-names></name></person-group><article-title>Infertility: Ultrasonic monitoring during replacement of frozen/thawed embryos in natural and hormone replacement cycles</article-title><source>Hum Reprod</source><year>1993</year><volume>8</volume><fpage>2068</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">8150904</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Sathanandan</surname><given-names>M</given-names></name><name><surname>Macnamee</surname><given-names>M</given-names></name><name><surname>Rainsbury</surname><given-names>P</given-names></name><name><surname>Wick</surname><given-names>K</given-names></name><name><surname>Brinsden</surname><given-names>P</given-names></name><name><surname>Edwards</surname><given-names>R</given-names></name></person-group><article-title>Replacement of frozen-thawed embryos in artificial and natural cycles: a prospective semi-randomized study</article-title><source>Hum Reprod</source><year>1991</year><volume>6</volume><fpage>685</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1939549</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Groenewoud</surname><given-names>ER</given-names></name><name><surname>Cantineau</surname><given-names>AE</given-names></name><name><surname>Kollen</surname><given-names>BJ</given-names></name><name><surname>Macklon</surname><given-names>NS</given-names></name><name><surname>Cohlen</surname><given-names>BJ</given-names></name></person-group><article-title>What is the optimal means of preparing the endometrium in frozen&#x02013;thawed embryo transfer cycles? A systematic review and meta-analysis</article-title><source>Hum Reprod Update</source><year>2013</year><volume>0</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Ghobara</surname><given-names>T</given-names></name><name><surname>Vanderkerchove</surname><given-names>P</given-names></name></person-group><article-title>Cycle regimens for frozen-thawed embryo transfer</article-title><source>Cochrane Database Syst Rev</source><year>2008</year><volume>(1)</volume><fpage>CD003414</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Tom&#x000e1;s</surname><given-names>C</given-names></name><name><surname>Alsbjerg</surname><given-names>B</given-names></name><name><surname>Martikainen</surname><given-names>H</given-names></name><name><surname>Humaidan</surname><given-names>P</given-names></name></person-group><article-title>Pregnancy loss after frozen-embryo transfer&#x02014;a comparison of three protocols</article-title><source>Fertil Steril</source><year>2012</year><volume>98</volume><fpage>1165</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22840239</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Morozov</surname><given-names>V</given-names></name><name><surname>Ruman</surname><given-names>J</given-names></name><name><surname>Kenigsberg</surname><given-names>D</given-names></name><name><surname>Moodie</surname><given-names>G</given-names></name><name><surname>Brenner</surname><given-names>S</given-names></name></person-group><article-title>Natural cycle cryo-thaw transfer may improve pregnancy outcome</article-title><source>J Assist Reprod Genet</source><year>2007</year><volume>24</volume><fpage>119</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">17450431</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>EM</given-names></name><name><surname>Han</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Lyu</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>WS</given-names></name><name><surname>Yoon</surname><given-names>TK</given-names></name></person-group><article-title>Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes</article-title><source>J Assist Reprod Genet</source><year>2011</year><volume>28</volume><fpage>369</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">21229386</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Kuwayama</surname><given-names>M</given-names></name></person-group><article-title>Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method</article-title><source>Theriogenology</source><year>2007</year><volume>67</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17055564</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Lahav-Baratz</surname><given-names>S</given-names></name><name><surname>Koifman</surname><given-names>M</given-names></name><name><surname>Shiloh</surname><given-names>H</given-names></name><name><surname>Ishai</surname><given-names>D</given-names></name><name><surname>Wiener-Megnazi</surname><given-names>Z</given-names></name><name><surname>Dirnfeld</surname><given-names>M</given-names></name></person-group><article-title>Analyzing factors affecting the success rate of frozen&#x02013;thawed embryos</article-title><source>J Assist Reprod Genet</source><year>2003</year><volume>20</volume><fpage>444</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14714822</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Urman</surname><given-names>B</given-names></name><name><surname>Balaban</surname><given-names>B</given-names></name><name><surname>Yakin</surname><given-names>K</given-names></name></person-group><article-title>Impact of fresh-cycle variables on the implantation potential of cryopreserved-thawed human embryos</article-title><source>Fertil Steril</source><year>2007</year><volume>87</volume><fpage>310</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17097088</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Gelbaya</surname><given-names>TA</given-names></name><name><surname>Nardo</surname><given-names>LG</given-names></name><name><surname>Hunter</surname><given-names>HR</given-names></name><name><surname>Fitzgerald</surname><given-names>CT</given-names></name><name><surname>Horne</surname><given-names>G</given-names></name><name><surname>Pease</surname><given-names>EE</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study</article-title><source>Fertil Steril</source><year>2006</year><volume>85</volume><fpage>603</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16500326</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Meng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Ai</surname><given-names>J</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Administration of calcitonin promotes blastocyst implantation in mice by up-regulating integrin &#x003b2;3 expression in endometrial epithelial cells</article-title><source>Hum Reprod</source><year>2012</year><volume>27</volume><fpage>3540</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">23001774</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Aghajanova</surname><given-names>L</given-names></name></person-group><article-title>Update on the role of leukemia inhibitory factor in assisted reproduction</article-title><source>Curr Opin Obstet Gynecol</source><year>2010</year><volume>22</volume><fpage>213</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20216416</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Fogle</surname><given-names>RH</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Paulson</surname><given-names>RJ</given-names></name></person-group><article-title>Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model</article-title><source>Fertil Steril</source><year>2010</year><volume>93</volume><fpage>1255</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19131054</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W-g</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group><article-title>Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation</article-title><source>PNAS</source><year>2003</year><volume>100</volume><fpage>2963</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12601161</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>R</given-names></name><name><surname>Jindal</surname><given-names>S</given-names></name><name><surname>Feil</surname><given-names>H</given-names></name><name><surname>Buyuk</surname><given-names>E</given-names></name></person-group><article-title>Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates</article-title><source>J Assist Reprod Genet</source><year>2017</year><volume>34</volume><fpage>1633</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">28823065</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Altm&#x000e4;e</surname><given-names>S</given-names></name><name><surname>Tamm-Rosenstein</surname><given-names>K</given-names></name><name><surname>Esteban</surname><given-names>FJ</given-names></name><name><surname>Simm</surname><given-names>J</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Endometrial transcriptome analysis indicates superiority of natural over artificial cycles in recurrent implantation failure patients undergoing frozen embryo transfer</article-title><source>Reprod Biomed Online</source><year>2016</year><volume>32</volume><fpage>597</fpage><lpage>613</lpage><pub-id pub-id-type="pmid">27090967</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Konc</surname><given-names>J</given-names></name><name><surname>Kanyo</surname><given-names>K</given-names></name><name><surname>Varga</surname><given-names>E</given-names></name><name><surname>Kriston</surname><given-names>R</given-names></name><name><surname>Cseh</surname><given-names>S</given-names></name></person-group><article-title>The effect of cycle regimen used for endometrium preparation on the outcome of day 3 frozen embryo transfer cycle</article-title><source>Fertil Steril</source><year>2010</year><volume>94</volume><fpage>767</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19917505</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Orvieto</surname><given-names>R</given-names></name><name><surname>Feldman</surname><given-names>N</given-names></name><name><surname>Lantsberg</surname><given-names>D</given-names></name><name><surname>Manela</surname><given-names>D</given-names></name><name><surname>Zilberberg</surname><given-names>E</given-names></name><name><surname>Haas</surname><given-names>J</given-names></name></person-group><article-title>Natural cycle frozen-thawed embryo transfer-can we improve cycle outcome?</article-title><source>J Assist Reprod Genet</source><year>2016</year><volume>33</volume><fpage>611</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">26973337</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Peeraer</surname><given-names>K</given-names></name><name><surname>Couck</surname><given-names>I</given-names></name><name><surname>Debrock</surname><given-names>S</given-names></name><name><surname>De Neubourg</surname><given-names>D</given-names></name><name><surname>De Loecker</surname><given-names>P</given-names></name><name><surname>Tomassetti</surname><given-names>C</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Frozen&#x02013;thawed embryo transfer in a natural or mildly hormonally stimulated cycle in women with regular ovulatory cycles: a RCT</article-title><source>Hum Reprod</source><year>2015</year><volume>30</volume><fpage>2552</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">26364081</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Groenewoud</surname><given-names>E</given-names></name><name><surname>Cohlen</surname><given-names>B</given-names></name><name><surname>Al-Oraiby</surname><given-names>A</given-names></name><name><surname>Brinkhuis</surname><given-names>EA</given-names></name><name><surname>Broekmans</surname><given-names>FJ</given-names></name><name><surname>de Bruin</surname><given-names>JP</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer</article-title><source>Hum Reprod</source><year>2016</year><volume>31</volume><fpage>1483</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">27179265</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Ghobara</surname><given-names>T</given-names></name><name><surname>Gelbaya</surname><given-names>TA</given-names></name><name><surname>Ayeleke</surname><given-names>RO</given-names></name></person-group><article-title>Cycle regimens for frozen-thawed embryo transfer</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><volume>7</volume><fpage>CD003414</fpage><pub-id pub-id-type="pmid">28675921</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Hancke</surname><given-names>K</given-names></name><name><surname>More</surname><given-names>S</given-names></name><name><surname>Kreienberg</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>JM</given-names></name></person-group><article-title>Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles</article-title><source>J Assist Reprod Genet</source><year>2012</year><volume>29</volume><fpage>403</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22391824</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal" publication-format="online"><person-group person-group-type="author"><name><surname>Le</surname><given-names>QV</given-names></name><name><surname>Abhari</surname><given-names>S</given-names></name><name><surname>Abuzeid</surname><given-names>OM</given-names></name><name><surname>DeAnna</surname><given-names>J</given-names></name><name><surname>Satti</surname><given-names>MA</given-names></name><name><surname>Abozaid</surname><given-names>T</given-names></name><name><surname>et</surname><given-names>al</given-names></name></person-group><article-title>Modified natural cycle for embryo transfer using frozen-thawed blastocysts: A satisfactory option</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><year>2017</year><volume>213</volume><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">28437630</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Demographic characteristics and clinical data of modified natural cycle frozen-thawed embryo transfer and artificial cycle-frozen-thawed embryo transfer groups</title></caption><graphic xlink:href="TJOD-15-12-g2"/></table-wrap><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Characteristics and pregnancy outcomes of frozen-thawed embryo transfer cycles</title></caption><graphic xlink:href="TJOD-15-12-g3"/></table-wrap><fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Participant consolitated standards of reparting trials flow diagram&#x0000d;
<italic>FET: Frozen-thawed embryo transfer</italic></title></caption><graphic xlink:href="TJOD-15-12-g1"/></fig></floats-group></article>